scholarly journals Implementation dilemmas of the Needle Syringe Exchange Programme (NSEP): Between the law and prevention

2016 ◽  
Vol 2 (2) ◽  
pp. 53-57 ◽  
Author(s):  
Paramjit Singh Jamir Singh ◽  
Azlinda Azman ◽  
Mohamad Shaharudin Samsurijan ◽  
Radin Firdaus Radin Badaruddin ◽  
Kumarashwaran Vadevelu ◽  
...  
The Lancet ◽  
1987 ◽  
Vol 329 (8534) ◽  
pp. 691-692 ◽  
Author(s):  
John Marks ◽  
Allan Parry

AIDS ◽  
1989 ◽  
Vol 3 (9) ◽  
pp. 571-576 ◽  
Author(s):  
Christina Hartgers ◽  
Ernst C. Buning ◽  
Gerrit W. van Santen ◽  
Annette D. Verster ◽  
Roel A. Coutinho

2015 ◽  
Vol 3 (2) ◽  
pp. 207-211
Author(s):  
Sharifah Fadzlon Abdul Hamid ◽  
Normah Omar ◽  
Suzana Sulaiman ◽  
Shu Hui Wee ◽  
Rusli Ismail

2017 ◽  
Vol 7 (2) ◽  
pp. 155-160 ◽  
Author(s):  
S. Chandrasekaran ◽  
N. T. T. Kyaw ◽  
A. D. Harries ◽  
I. A. Yee ◽  
P. Ellan ◽  
...  

2005 ◽  
Vol 134 (4) ◽  
pp. 814-819 ◽  
Author(s):  
K. STARK ◽  
U. HERRMANN ◽  
S. EHRHARDT ◽  
U. BIENZLE

In two prisons in Berlin, Germany, provision of sterile injection equipment for injecting drug users (IDUs) started in 1998. To assess the programme's impact, the frequency of injecting drug use and syringe sharing, and the incidence of HIV, HBV, and HCV infection were determined in a follow-up study. Of all IDUs (n=174), 75% continued to inject. After the project start the level of syringe sharing declined from 71% during a 4-month period of previous imprisonment to 11% during the first 4 months of follow-up, and to virtually zero thereafter. Baseline seroprevalences for HIV, HBV, and HCV were 18, 53, and 82%. HIV and HCV seroprevalence at baseline was significantly associated with drug injection in prison prior to the project start. No HIV and HBV seroconversions, but four HCV seroconversions occurred. The provision of syringes for IDUs in appropriate prison settings may contribute to a substantial reduction of syringe sharing. However, the prevention of HCV infection requires additional strategies.


2015 ◽  
Vol 20 (3) ◽  
pp. 72-84 ◽  
Author(s):  
Paula Leslie ◽  
Mary Casper

“My patient refuses thickened liquids, should I discharge them from my caseload?” A version of this question appears at least weekly on the American Speech-Language-Hearing Association's Community pages. People talk of respecting the patient's right to be non-compliant with speech-language pathology recommendations. We challenge use of the word “respect” and calling a patient “non-compliant” in the same sentence: does use of the latter term preclude the former? In this article we will share our reflections on why we are interested in these so called “ethical challenges” from a personal case level to what our professional duty requires of us. Our proposal is that the problems that we encounter are less to do with ethical or moral puzzles and usually due to inadequate communication. We will outline resources that clinicians may use to support their work from what seems to be a straightforward case to those that are mired in complexity. And we will tackle fears and facts regarding litigation and the law.


Sign in / Sign up

Export Citation Format

Share Document